Proton Radiotherapy for Primary Central Nervous System Tumours in Adults

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

Also called NCT02797366

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02797366
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT02797366. Allocation not applicable; no masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2020-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Proton Radiotherapy for Primary Central Nervous System Tumours in Adults
Acronym
PRO-CNS
Condition
Central Nervous System Tumour
Condition
Arteriovenous Malformation
Intervention (Radiation)
Proton radiotherapy
Lead sponsor
Uppsala University (class: other)
Collaborator
Sahlgrenska University Hospital (class: other)
Collaborator
Karolinska University Hospital (class: other)
Collaborator
University Hospital, Umeå (class: other)
Collaborator
Region Örebro County (class: other)
Collaborator
University Hospital, Linkoeping (class: other)

Record details

Record id
cardio:ct-nct02797366
Content hash
31129aec18e5dc122d981131e6f7954fabb2563814dffdc8793a3b99cf81bc74